ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01DD15 | B | Cefdinir - 125mg/5ml | 8840 | 87016/1 | OMNICEF | 125mg/5ml | 80ml | Powder for suspension | Oral | Droguerie de l'Union | Jazeera Pharmaceutical Industries under licence of Astellas Pharma Inc Japan | Saudi Arabia | 1,644,052 L.L | 23.08 | B | Hikma Pharmaceuticals | Jordan | 01/02/2023 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01DD15 | B | Cefdinir - 125mg/5ml | 3560 | 148399/04 | OMNICEF | 125mg/5ml | 40ml | Powder for suspension | Oral | Droguerie de l'Union | Hikma Pharmaceuticals under license of Astellas Pharma Inc Japan | Jordan | 881,621 L.L | 23.08 | A2 | 01/02/2023 | 0 | ||
J01DD15 | B | Cefdinir - 125mg/5ml | 3561 | 195098/04 | OMNICEF | 125mg/5ml | 80ml | Powder for suspension | Oral | Droguerie de l'Union | Hikma Pharmaceuticals under license of Astellas Pharma Inc Japan | Jordan | 1,644,052 L.L | 23.08 | B | 01/02/2023 | 0 | ||
J01DD15 | B | Cefdinir - 125mg/5ml | 8841 | 87116/1 | OMNICEF | 125mg/5ml | 40ml | Powder for suspension | Oral | Droguerie de l'Union | Jazeera Pharmaceutical Industries under licence of Astellas Pharma Inc Japan | Saudi Arabia | 881,621 L.L | 23.08 | A2 | Hikma Pharmaceuticals | Jordan | 01/02/2023 | 0 |
J01DD15 | G | Cefdinir - 125mg/5ml | 7910 | 31414/1 | SEFARIN | 125mg/5ml | 100ml | Suspension | Oral | Picomed SARL | Pharma International Co Ltd | Jordan | 1,194,729 L.L | 23.08 | B | Pharma International Co Ltd | Jordan | 01/02/2023 | 0 |
J01DD15 | G | Cefdinir - 125mg/5ml | 8227 | 50715/1 | SEFARIN | 125mg/5ml | 50ml | Suspension | Oral | Picomed SARL | Pharma International Co Ltd | Jordan | 661,216 L.L | 23.08 | A2 | Pharma International Co Ltd | Jordan | 01/02/2023 | 0 |